|
The biotech’s potential launch on the public markets would help fuel development of its clinical-stage, melanocortin-focused pipeline.
|
 |
|
Fresh with a rebrand, Cyllene will advance gene therapies built on a platform that uses a modified form of the herpes virus for delivery.
|
|
|
Vivani’s NanoPortal technology delivers medication steadily over long periods of time.
|
|
|
The collaboration leverages Biocytogen’s antibody capabilities and Whitehawk’s ADC expertise to identify BsADCs.
|
|
|
The status was granted by the FDA's Office of Orphan Products Development and Office of Pediatric Therapeutics.
|
|
|
The acquisition is expected to close in the third quarter of 2026.
|
|
